(Q42198417)

18 October 2017

Genetic predisposition to drug hepatotoxicity: role in hepatitis caused by amineptine, a tricyclic antidepressant (English)

1 reference

18 October 2017

1 reference

D Larrey

1

1 reference

18 October 2017

A Berson

2

1 reference

18 October 2017

F Habersetzer

3

1 reference

18 October 2017

M Tinel

4

1 reference

18 October 2017

A Castot

5

1 reference

18 October 2017

G Babany

6

1 reference

18 October 2017

P Lettéron

7

1 reference

18 October 2017

E Freneaux

8

1 reference

18 October 2017

J Loeper

9

1 reference

18 October 2017

P Dansette

10

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 August 1989

1 reference

18 October 2017

1 reference

18 October 2017

10

1 reference

18 October 2017

168-173

1 reference

18 October 2017

2

1 reference

Polymorphism of dextromethorphan oxidation in a French population

18 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

Metabolic activation of the tricyclic antidepressant amineptine--I. Cytochrome P-450-mediated in vitro covalent binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Metabolic activation of the tricyclic antidepressant amineptine--II. Protective role of glutathione against in vitro and in vivo covalent binding

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Metabolic activation of the tricyclic antidepressant amineptine by human liver cytochrome P-450.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Genetically determined polymorphisms in drug oxidation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Impaired oxidation of debrisoquine in patients with perhexiline liver injury

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Glutathione synthetase-deficient lymphocytes and acetaminophen toxicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Predisposition to phenytoin hepatotoxicity assessed in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Halothane hepatitis. Detection of a constitutional susceptibility factor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Amitriptyline-induced prolonged cholestasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Formation and inactivation of a chemically reactive metabolite of vinyl chloride

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

HLA antigens in patients with unexplained hepatitis following halothane anesthesia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100208

7 January 2021

Identifiers

DOI

10.1002/HEP.1840100208

1 reference

18 October 2017

1 reference